Alimetry secures $18 million to advance wearable gut health monitoring

Nov 04, 2024

Carolyn Marks and Joel Svensson

In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research.

Previous: Vikings Finally Get Justice for Sam Darnold Face Mask vs. Rams Next: 2024 Gold Glove Award winners: Bobby Witt Jr., Carlos Santana among 14 first-time honorees - The Athletic

Send inquiry

Send